Benzinga | Dec 10, 2021 05:05AM EST

RBC Capital Initiates Coverage On Edwards Lifesciences with Outperform Rating, Announces Price Target of $142

RBC Capital analyst Shagun Singh initiates coverage on Edwards Lifesciences (NYSE:EW) with a Outperform rating and announces Price Target of $142.